Weighted Average Number of Shares Outstanding, Basic of Alaunos Therapeutics, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Alaunos Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Alaunos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 2,183,039, a 36% increase year-over-year.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,601,252, a 0.11% increase from 2023.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1,599,532, a 89% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14,475,354, a 93% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Alaunos Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,183,039 +581,787 +36% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,676,345 +76,039 +4.8% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,601,252 0 0% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,601,252 +1,720 +0.11% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 1,601,252 +946 +0.06% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 1,600,306 +1,656 +0.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 1,601,252 -14,377,371 -90% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 1,599,532 -12,875,822 -89% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 1,600,306 -213,498,689 -99% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 1,598,650 -213,400,243 -99% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 15,978,623 -198,967,946 -93% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 14,475,354 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 215,098,995 +556,530 +0.26% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 214,998,893 +572,487 +0.27% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 214,946,569 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q3 2021 214,542,465 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 214,426,406 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q3 2012 78,670,222 +10,565,288 +16% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 78,514,718 +11,285,620 +17% 01 Apr 2012 30 Jun 2012 10-Q/A 28 Aug 2012 2012 Q2
Q3 2011 68,104,934 +20,677,943 +44% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 67,229,098 +24,864,307 +59% 01 Apr 2011 30 Jun 2011 10-Q/A 28 Aug 2012 2012 Q2
Q3 2010 47,426,991 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 42,364,791 01 Apr 2010 30 Jun 2010 10-Q/A 09 Aug 2011 2011 Q2

Alaunos Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,601,252 +1,720 +0.11% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 1,599,532 -12,875,822 -89% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 14,475,354 -199,923,720 -93% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 214,399,074 +4,762,618 +2.3% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 209,636,456 +41,684,342 +25% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 167,952,114 +24,443,440 +17% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2021 2020 FY
2018 143,508,674 +6,570,410 +4.8% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 136,938,264 +6,546,801 +5% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 130,391,463 01 Jan 2016 31 Dec 2016 10-K 05 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.